Abstract
The controversial point of treatment for oropharyngeal cancer is the surgical approach and it is in transition, especially for resectable tumors. Transcervical oropharyngectomy with mandibulotomy is an oncologically valid surgical option for resectable T3–T4a oropharyngeal cancers and contraindications for transoral lateral oropharyngectomy. The approach without mandibulotomy allows for simple reconstruction and has a low complication rate. In particular, it spares the patients’ morbidity related to mandibulotomy.
The transoral approach, especially with robotic surgical systems seem likely to offer an alternative approach and refinement of oropharuyngectomy in the future.
Keywords: Advanced oropharyngeal carcinoma, mandibulotomy, transcervical oropharyngectomy.
Current Cancer Therapy Reviews
Title:Transcervical Oropharyngectomy: A Clinically Focused Review
Volume: 11 Issue: 1
Author(s): Yasuhisa Hasegawa
Affiliation:
Keywords: Advanced oropharyngeal carcinoma, mandibulotomy, transcervical oropharyngectomy.
Abstract: The controversial point of treatment for oropharyngeal cancer is the surgical approach and it is in transition, especially for resectable tumors. Transcervical oropharyngectomy with mandibulotomy is an oncologically valid surgical option for resectable T3–T4a oropharyngeal cancers and contraindications for transoral lateral oropharyngectomy. The approach without mandibulotomy allows for simple reconstruction and has a low complication rate. In particular, it spares the patients’ morbidity related to mandibulotomy.
The transoral approach, especially with robotic surgical systems seem likely to offer an alternative approach and refinement of oropharuyngectomy in the future.
Export Options
About this article
Cite this article as:
Hasegawa Yasuhisa, Transcervical Oropharyngectomy: A Clinically Focused Review, Current Cancer Therapy Reviews 2015; 11 (1) . https://dx.doi.org/10.2174/157339471101150706122028
DOI https://dx.doi.org/10.2174/157339471101150706122028 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Perspectives in Glioma Immunotherapy
Current Pharmaceutical Design Cancer Therapeutics-Related Cardiovascular Complications. Mechanisms, Diagnosis and Treatment
Current Pharmaceutical Design Bladder Cancer Stem Cells: Biological and Therapeutic Perspectives
Current Stem Cell Research & Therapy New Therapeutic Applications of Phosphodiesterase 5 Inhibitors (PDE5-Is)
Current Medicinal Chemistry Emergence of Functionalized Nanomedicines in Cancer Chemotherapy: Recent Advancements, Current Challenges and Toxicity Considerations
Recent Patents on Nanomedicine Current Biomarkers for Lung Cancer
Current Signal Transduction Therapy COX-2, Cell Proliferation and PMA in Head-and-Neck Cancer Cells
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Improved Pharmacokinetic Profile and Anti-Inflammatory Property of a Novel Curcumin Derivative, A50
Letters in Drug Design & Discovery MDA-7/IL-24-Based Cancer Gene Therapy: Translation from the Laboratory to the Clinic
Current Gene Therapy Proteinases as Biomarkers in Breast Cancer Prognosis and Diagnosis
Mini-Reviews in Medicinal Chemistry Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far
Recent Patents on Anti-Cancer Drug Discovery Risk Factors for Lung Cancer in Never Smokers: A Recent Review Including Genetics
Current Respiratory Medicine Reviews Recent Updates on the Therapeutic Potential of HER2 Tyrosine Kinase Inhibitors for the Treatment of Breast Cancer
Current Cancer Drug Targets Combination of DC Vaccine and Conventional Chemotherapeutics
Anti-Cancer Agents in Medicinal Chemistry MicroRNAs as Diagnostic, Prognostic and Predictive Biomarkers of Ovarian Cancer
Recent Patents on Biomarkers The Discovery of Antiangiogenic Molecules: A Historical Review
Current Pharmaceutical Design Overview of Mechanisms of Cancer Stem Cell Drug Resistance
Current Signal Transduction Therapy The Prominent Role of Protein-Based Delivery Systems on the Development of Cancer Treatment
Current Pharmaceutical Design Vitamin D3 and Vitamin D3 Analogues as an Adjunct to Cancer Chemotherapy and Radiotherapy
Current Medicinal Chemistry - Anti-Cancer Agents Butyrate and Colorectal Cancer: The Role of Butyrate Transport
Current Drug Metabolism